[
1. Arnal MJD, Arenas ÁF, Arbeloa ÁL. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol 2015;21(26):7933-7943.10.3748/wjg.v21.i26.7933449933726185366
]Search in Google Scholar
[
2. Lou F, Sima CS, Adusumilli PS, et al. Esophageal Cancer Recurrence Patterns and Implications for Surveillance. J Thorac Oncol 2013;8(12):1558-1562.10.1097/01.JTO.0000437420.38972.fb406687524389438
]Search in Google Scholar
[
3. Matsuda S, Takeuchi H, Kawakubo H, Kitagawa Y. Three-field lymph node dissection in esophageal cancer surgery. J Thorac Dis 2017;9:S731-40.10.21037/jtd.2017.03.171553899428815069
]Search in Google Scholar
[
4. Kumagai K, Rouvelas I, Tsai JA, et al. Metaanalysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. Br J Surg 2014;101(4):321-38.10.1002/bjs.941824493117
]Search in Google Scholar
[
5. Samalin E, Ychou M. Neoadjuvant therapy for gastroesophageal adenocarcinoma. World J Clin Oncol 2016;7(3):284-292.10.5306/wjco.v7.i3.284489689627298768
]Search in Google Scholar
[
6. Qin Q, Xu H, Liu J, et al. Does timing of esophagectomy following neoadjuvant chemoradiation affect outcomes? A metaanalysis. Int J Surg 2018;59:11–18.10.1016/j.ijsu.2018.09.01330261331
]Search in Google Scholar
[
7. Noordman BJ, Verdam MGE, Lagarde SM, et al. Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial. Ann Oncol 2018;29:445-451.10.1093/annonc/mdx72629126244
]Search in Google Scholar
[
8. Zhao X, Ren Y, Hu Y, et al. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials. PLOS ONE 2018;13(8):e0202185.10.1371/journal.pone.0202185610714530138325
]Search in Google Scholar
[
9. Deng HY, Wang WP, Wang YC, et al. Neoadjuvant chemoradiotherapy or chemotherapy? A comprehensive systematic review and meta-analysis of the options for neoadjuvant therapy for treating oesophageal cancer. Eur J Cardiothorac Surg 2017;51(3):421-31.
]Search in Google Scholar
[
10. Ajani JA, D’Amico TA, Bentrem DJ, et al. Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2019;17(7):855-883.10.6004/jnccn.2019.003331319389
]Search in Google Scholar
[
11. Ji KSY, Thomas SM, Roman SA, et al. Low- vs. High-Dose Neoadjuvant Radiation in Trimodality Treatment of Locally Advanced Esophageal Cancer. J Gastrointest Surg 2019;23(5):885-894.10.1007/s11605-018-4007-330374818
]Search in Google Scholar
